Inter- patientvariationerne i et steady state - studie af Alzheimers demens var højst 45% (Cmax) og 43% (AUC0- 24h) efter brug af depotplasteret, og henholdsvis 71% og 73% efter administration af den orale formulering.
The inter-patient variability in a steady-state study in Alzheimer’ s dementia was at most 45% (Cmax) and 43% (AUC0-24h) after use of the transdermal patch, and 71% and 73%, respectively, after administration of the oral form.